RefBan

Referral Banners

Yashi

Monday, April 28, 2014

Reuters Health Report

Click to View in Browser
04/28/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Bayer may sell plastics unit to focus on health: Bloomberg
(Reuters) - German drugmaker Bayer AG is exploring the sale of its $10 billion plastics unit to focus on growing its health business, Bloomberg reported citing people with knowledge of the matter.
U.S. military suicides fall among active duty, rise in reserves
WASHINGTON (Reuters) - Suicides among active duty U.S. forces fell 18 percent in 2013 from a peak in 2012 but climbed among reserve forces, the Pentagon said on Friday as it unveiled figures showing suicide still far outpaced combat deaths among U.S. military personnel.
Saudi Arabia has 26 more cases of MERS virus, 10 dead
RIYADH (Reuters) - Saudi Arabia confirmed 26 more cases of Middle East Respiratory Syndrome (MERS), which has killed nearly a third of sufferers, and said 10 more people have died from the disease.
Killer virus spreads unchecked through U.S. hog belt, pushing pork to record
CHICAGO (Reuters) - John Goihl, a hog nutritionist in Shakopee, Minnesota, knows a farmer in his state who lost 7,500 piglets just after they were born. In Sampson County, North Carolina, 12,000 of Henry Moore's piglets died in three weeks. Some 30,000 piglets perished at John Prestage's Oklahoma operation in the fall of 2013.
FDA okays start of BrainStorm stem cell trial in ALS patients
TEL AVIV (Reuters) - BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration approved the start of a mid-stage clinical trial of its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS).
Egypt discovers first case of potentially deadly MERS virus
CAIRO (Reuters) - Egypt has discovered its first case of the potentially deadly Middle East Respiratory Syndrome (MERS) in an Egyptian citizen who had recently returned from Saudi Arabia, Egypt's Ministry of Health said on Saturday.
Pfizer chasing AstraZeneca for potential $100 billion deal
LONDON (Reuters) - U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion battle for Britain's AstraZeneca Plc after having two bids rejected, as deal-making grips the healthcare industry.
Pfizer's move on Astra fuels fears for British science
LONDON (Reuters) - Pfizer's plan to snap up its smaller rival AstraZeneca has stoked concerns about Britain's ability to remain a leader in life sciences, even as the U.S. drugmaker insists that it highly values UK research.
France meets Alstom bidders with pledge to protect jobs
PARIS (Reuters) - France said it would defend jobs and its national interest as it met suitors for engineering group Alstom on Monday, suggesting Germany's Siemens may have an edge over U.S. giant General Electric.
Germany voices support for Siemens-Alstom deal
BERLIN (Reuters) - The German government voiced support on Monday for a deal between Siemens and France's Alstom, saying mooted plans for a swap of energy and rail assets could offer "great opportunities" for both countries.
Related Video
Protesters march to stop Keystone XL pipeline
One million endangered orchids to be planted in South Florida
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika